Aug
2026
COEX, Seoul, Korea
Visit us
stand EE30

BLIS Technologies

Exhibitor at CPHI Korea 2026
About Us

PROBIOTICS MADE TO MATTER

BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health.

We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.


  • Country/Region:
    New Zealand
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • 10, Birch St,Dunedin,PO Box No 2208,, 9059, Dunedin, New Zealand
Event information
CPHI Korea 2026
  • 25 Aug 2026 - 27 Aug 2026
  • COEX, Seoul, Korea
  • Visit us at stand EE30

Products Featured at CPHI Korea 2026

  • BLIS K12™ (Streptococcus salivarius K12)

    Product BLIS K12™ (Streptococcus salivarius K12)

    BLIS K12™ (Streptococcus salivarius K12) is an oral probiotic to support mouth and throat. It originates from the oral microbiome and targets multiple concerns, including ENT (ears, nose and throat) health, immunity and bad breath. • Helps maintain a healthy oral microbiome • Supports ear, nose, and ...
  • BLIS M18™ (Streptococcus salivarius M18)

    Product BLIS M18™ (Streptococcus salivarius M18)

    BLIS M18™ (Streptococcus salivarius M18) is an oral probiotic to support teeth and gum health. It originates from the oral microbiome and is proven to maximise good dental hygiene, for the support of teeth, gums and overall health.

BLIS Technologies Ltd Resources (1)

  • Video PROBIOTICS MADE TO MATTER | BLIS TECHNOLOGIES

    BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health. We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.